Background: A distinct neuroanatomical indicator for Post-traumatic Stress Disorder (PTSD) soon after exposure is still lacking. Contradictory findings regarding the hippocampus as a potential early risk factor could be related to the overlooked contribution of developmental brain anomaly. One such anomaly could be a persistently enlarged cavum septum pellucidum (CSP), which has been associated with PTSD. To test this assertion, we performed a longitudinal volumetric MRI study on trauma survivors, within one-, six-and fourteen-months after trauma. We hypothesized that at onemonth post-trauma, the relation between hippocampal volume and PTSD severity would be moderated by CSP volume, and that this early interaction would account for persistent PTSD symptoms at subsequent time points.
Introduction
More than 70% of adults worldwide experience a traumatic event at some time in their lives 1 , yet only a subset of these individuals (1.3% to 12.2%) will develop post-traumatic stress disorder (PTSD) 2 , a highly debilitating mental health disorder, often resistant to existing therapeutics [3] [4] [5] [6] . Although accumulating findings point to a neural origin of this post-exposure personal outcome, reliable risk factors of vulnerability to develop traumatic stress psychopathology have yet to be discovered [7] [8] [9] . Such vulnerability factors could allow accurate diagnosis and therapeutic intervention in the early aftermath of the traumatic event, which has been shown to reduce the likelihood of developing chronic PTSD [10] [11] [12] .
The most replicated structural abnormality found in PTSD is lower hippocampal volume [13] [14] [15] [16] [17] [18] , with substantial evidence that this could represent a risk factor for PTSD, including studies on twins with different life experience 19, 20 . It seems that the hippocampus may have a multifaceted role in PTSD pathogenesis, including the formation and recall of memory traces for contextual information of traumatic events, and providing a representation of safety or danger of the situation 21 . Intriguingly, the hippocampus seems to play a dynamic role in both post-traumatic psychopathology and recovery from trauma. While hippocampal volume reduction was observed after trauma exposure 22 and in chronic PTSD 23 , increased hippocampal volume was associated with clinical improvement of PTSD symptoms 24 . Nevertheless, trauma exposure even in the absence of PTSD was shown to be associated with hippocampal volume deficits 22 , and further hippocampal volume reduction was seen in chronic PTSD 23 . Taken together, controversy exists as to whether reduced hippocampal size in PTSD is the result of trauma exposure, represents a risk factor for PTSD, or a combination of both 23, 25, 26 . It might be that the hippocampus is not the only structural change in PTSD, and its impact depends on related brain development anomaly.
One such commonly seen anomaly is persistent enlarged Cavum Septum Pellucidum (CSP), known to be related to disturbed brain development 27, 28 . The CSP, sometimes inaccurately referred to as "fifth ventricle", is a small cleft filled with cerebrospinal fluid (CSF), located between two thin translucent leaflet membranes, that extends from the anterior part of the corpus callosum to the superior surface of the fornix. In normal development, the fusion of the septi pellucidi occurs within three to six months of age, due to rapid growth of the hippocampal alvei and the corpus callosum 29 .
However, in some cases the two leaves of the septum pellucidum do not completely fuse, resulting in persistent CSP, which above a certain size, may reflect neurodevelopmental anomaly in midline structures of the brain 27,30 (see Fig. 1 ). Therefore, persistent enlarged CSP in adults may reflect developmental abnormalities of brain structures bordering the septum pellucidum, such as the hippocampus 29,31 .
A wide variance in the prevalence of CSP in healthy adults has been reported, depending on the method of detection, definition criteria, and homogeneity of the population 28,32-37 . In clinical population, abnormally large CSP was associated with schizophrenia 28, 32, 42, [33] [34] [35] [36] [38] [39] [40] [41] , bipolar disorders 35, 43, 44 , and others psychopathologies 45, 46 . However, other studies did not find higher rates of enlarged CSP in schizophrenia [47] [48] [49] or other psychiatric disorders [50] [51] [52] [53] , making it difficult to determine its connection to psychopathology in a systematic and reliable manner. Interestingly, in patients with schizophrenia and an enlarged CSP, smaller amygdala and posterior parahippocampal gyrus volumes were also found (compared to schizophrenia patients without CSP) 54 .
To date, only two studies have addressed the relationship between the presence of enlarged CSP and PTSD symptomatology. A pioneer study by Myslobodsky et al (1995) 55 has reported increased incidence of CSP (50%) in combat veterans with PTSD, compared with matched normal volunteers (14%), suggesting the CSP might be an antecedent marker for psychopathological vulnerability to stress. More recently, May et al. (2004) 56 found there was a greater proportion of abnormal CSP in combat-exposed twins with PTSD and their noncombat-exposed co-twins, suggesting that the presence of an abnormal CSP may serve as a familial vulnerability factor for PTSD. However, the authors also suggested that PTSD vulnerability is not contributed directly by abnormal CSP itself, but rather indirectly by some neurodevelopmental third factor.
Here, we tested the relationship between CSP volume and hippocampus volume in a large population of recent trauma survivors using a longitudinal approach. Specifically, we examined hippocampus and CSP volumes within on one-month after trauma, and PTSD symptoms at one-, six-, and fourteen-month following trauma exposure. CSP and hippocampal three-dimensional volumes were assessed using automated tools to provide a continuous measure of size of a reliably demarcated region. While for the hippocampus this automated approach has been validated in multiple studies 57-59 , for the CSP, as far as we know, no such studies were reported. Therefore, we employed an additional validation procedure by a blinded neuroradiologist for the automated CSP assessment.
Given the consistent finding of low hippocampal volume in PTSD, and the potential of enlarged CSP to serve as vulnerability factor for stress psychopathology, we hypothesized that the relationship between hippocampal volume and post-traumatic stress symptoms will be moderated by CSP volume. More specifically, we hypothesized that individuals with lower hippocampal volume and higher CSP volume would exhibit more severe PTSD symptoms at one-month posttrauma. To test this assumption, we employed a regression model in which we examined the ability of the interaction effect between hippocampal and CSP volumes to predict post-traumatic stress symptoms. Using the same regression model, we further examined the predictive power of this relation between hippocampus and CSP volumes at one-month post-trauma, with respect to subsequent PTSD symptom severity at six-and fourteen-month post-trauma.
Methods and Materials
The present study is part of a larger scale on-going project. Here we present results obtained from all the participants which completed clinical and neural assessments within one-month following the traumatic incidents (n=171). Out of these 171 individuals, we also present results of n=97 and n=78 which currently completed clinical assessments at six-and fourteen-month posttrauma (respectively).
Participants
Participants were adult survivors of potentially traumatic events, admitted to a Medical Center's Emergency Room (ER). Individuals were considered for a telephone screening interview if they met the following inclusion criteria: (i) Age 18 -65 years (ii) Able to read and comprehend native language (iii) Arrived in the ER due to motor-vehicle accidents, bicycle accidents, physical assaults, terrorist attacks, work accidents, large-scale disaster or other trauma types. To reduce confounds related to concurrent disorders, the exclusion criteria included: (i) survivors with head trauma with coma exceeding a 30 minutes upon ER arrival; (ii) survivors with known medical condition that will interfere with their ability to give informed consent, cooperate with screening and/or treatment; (iii) survivors with claustrophobia, incompatibility for MRI scan, history of substance abuse, current or past psychotic disorder, chronic PTSD; (iv) individuals using psychotropic medication or recreational drugs in the week that precedes the assessment.
Procedure
A member of the research team identified potentially trauma-exposed individuals using the ER medical records. Within 10-14 days after potential trauma exposure, the identified individuals were contacted by telephone. After verbal consent, risk of PTSD development was assessed using a modified dichotomous version of the PTSD Checklist (PCL) questionnaire 61 . Participants which met PTSD symptom criteria or at least part of it, and did not meet any of the exclusion criteria, received verbal information about the study. They were subsequently invited to participate in both comprehensive clinical assessment and a high-resolution MRI scan, within one-month post-trauma (TP1). Two identical follow-up meetings (including both clinical and neural assessments) were conducted at six-and fourteen-month after trauma (TP2 and TP3, respectively). The study met all ethical regulations as required by ethics committee in the local Medical Center (Reference number 0207/14). All participants gave written informed consent in accordance with the Declaration of Helsinki. The study ClinicalTrials.gov registration number is NCT03756545.
Clinical Assessment
The clinical status of participants was determined by the Clinician-Administered PTSD Scale (CAPS) 62,63 , structured clinical interview corresponding to DSM-based PTSD criteria as determined by dimensions of frequency, intensity, and severity of symptoms. An instrument combining both CAPS-4 and CAPS-5 was used, based on DSM-IV and DSM-5 criteria, accordingly. The CAPS contain explicit, behaviorally anchored questions and rating scale descriptors to enhance reliability. It yields a continuous symptom severity score, obtained by summing individual items' scores (each item ranges from 0-4, with 0 being absent to 4 being extreme/incapacitating).
Magnetic Resonance Imaging (MRI)
Acquisition. MRI scans were conducted using a Siemens 3T MAGNETOM scanner, located at the Tel Aviv Sourasky Medical Center. In order to assess subcortical and cortical volumes, as well cortical thickness, we used a high resolution sagittal T 1 -weighted magnetization prepared rapid gradient echo (MPRAGE) sequence (TE=2.29 msec, TR=2400 msec, flip angle=8°, FOV =224 mm, Slice Thickness 0.70 mm, voxel size 0.7x0.7x0.7 mm).
Analysis. Cortical reconstruction and volumetric segmentation was performed with the FreeSurfer (FS) image analysis suite 64 , which is documented and freely available for download online (http://surfer.nmr.mgh.harvard.edu/). Right and left hippocampal and CSP volumes were derived from this process for each subject. The automated hippocampal volumetric measurement by FS was previously shown to have a good agreement with manual hippocampal volumetric assessment, as well as with other automatic methods 58,65,66 ; however, this was not done for CSP volumetric measurement. In order to validate the automated measurement of the CSP, individuals' CSP sizes were manually verified by a senior neuroradiologist (D.N.) who was blinded to participants' clinical symptoms. For each subject, the FS mask of the CSP was evaluated independently according to its correct location and intensity. Based on this blind assessment, participants were divided into two groups: those in which there was agreement between the FS marking and the manual neuroradiologist evaluation, and those in which there was disagreement between the two (hence were excluded from the final analysis).
Statistical Analysis
In order to test whether CSP volume moderated the relationship between bilateral hippocampal volume and PTSD symptoms, moderation analysis including hierarchical multiple regression analysis was conducted using PROCESS macro for SPSS 67, 68 . In the first step, two independent variables (bilateral hippocampus and CSP volumes at TP1), alongside four covariates (participants' age, gender, trauma type and intracranial volume (ICV)), were used to predict the dependent variable (PTSD symptom severity as measured by CAPS-4 or CAPS-5 total scores). In the second step of the regression, the centered interaction term between hippocampal volume and CSP volume was added to the regression model to test its contribution. Significant interactions were probed by testing the conditional effects of CSP volume at the different quartiles of hippocampal volume (Q1=25th percentile, Q2=50th percentile=Median, Q3=75th percentile).
In accordance with common norms, the skewed distribution of CSP volume was treated by adding a constant (b=1.25) to the original values of CSP volume, and then a log transformation was performed on these modified values 69 . Bilateral hippocampal volume, and total scores of both CAPS-4 and CAPS-5 followed a normal distribution, therefore did not require transformations.
Furthermore, to reduce the threat of multi-collinearity, both hippocampal and CSP volumes were centered prior to analyses, and an interaction term between these two was created 70 .
Results
A total of 171 participants completed clinical and neural assessments within one-month following their traumatic incident (TP1). Out of which, 10 individuals were excluded from the analysis due to a missing MPRAGE sequence (n=3), missing clinical data (n=3), or poor quality structural scan (n=4). The CSP sizes of the remaining 161 participants were manually verified by a senior neuroradiologist (see MRI Analysis under Methods and Materials). Based on this blind assessment, for 28 participants (17%) there was a disagreement between the FS marking and the manual neuroradiologist evaluation, hence they were excluded from the analysis. For the remaining 133 participants, there was an agreement between the FS marking and the manual neuroradiologist evaluation, hence they were included in the final analyses described below.
The majority of the traumatic events which the participants exhibited were motor-vehicle accidents (n=108, 81%). The other most common types of trauma included bicycle accidents (n=13, 10%) and physical assaults (n=11, 8%). For the follow-up assessments, n=97 and n=78 participants which completed clinical assessments at six-and fourteen-month post-trauma (TP2 and TP3; respectively), were included in the final analyses. No significant differences were found between the 97 individuals which completed TP2 assessments and the 36 which did not, in bilateral hippocampal volume (p=0.747), CSP volume (p=0.491), or ICV (p=0.813). Furthermore, no significant differences were found between the 78 individuals which completed TP3 assessments and the 19 which did not, in bilateral hippocampal volume (p=0.220), CSP volume (p=0.990), or ICV (p=0.650). For further demographic, clinical, and neuroanatomical characteristics of all participants along the three time-points, refer to Table 1 .
Volumetric markers of PTSD symptom severity at one-month after trauma exposure (TP1)
To test the hypothesis that PTSD symptoms one-month after trauma are a function of multiple volumetric abnormalities, and more specifically whether CSP volume moderates the relationship between hippocampal volume and PTSD severity, a hierarchical multiple regression analysis was conducted (see details under Statistical Analysis). Results showed that bilateral hippocampus volume and CSP volume, alongside four covariates (participants' age, gender, trauma type and ICV), accounted for a significant amount of variance of total scores of both CAPS-4 (R 2 = 0.323, F(6, 126) = 2.439, p = 0.029). After the interaction term between hippocampal volume and CSP volume was added, the regression model accounted for a significant change in proportion of CAPS-4 total scores (ΔR 2 = 0.035, Δ F(1,125) = 5.057 , p = 0.026). Consistent with our hypothesis, a significant interaction (moderation) effect was found between bilateral hippocampus volume and CSP volume in predicting CAPS-4 total scores at one-month post-trauma (b = -0.0134, t(125) = -2.249, p = 0.026) (See Table 2 ). Importantly, neither hippocampal volume nor CSP volume by themselves predicted CAPS-4 total scores (p = 0.109; p = 0.183, respectively).
The above-mentioned interaction was probed by testing the conditional effects of CSP volume at the different quartiles of hippocampal volume (Q1=25th percentile, Q2=50th percentile=Median, Q3=75th percentile) (see Fig. 2) . At low hippocampal volume (Q1), CSP volume was significantly related to PTSD severity (CAPS-4: p=0.008; CAPS-5: p=0.028).
However, at median and high hippocampal volumes (Q2 and Q3 respectively), the relationship between CSP and hippocampus was not significant (p>0.15 for both CAPS-4 and CAPS-5) (see Fig. 2 ).
When using CAPS-5 total scores (instead of CAPS-4) to assess PTSD symptom severity with identical statistical approach, the regression model accounted for a significant amount of variance of CAPS-5 total scores (R 2 = 0.332, F(6, 126) = 2.603, p = 0.021). After the interaction term was added, the regression model accounted for a marginally significant change in proportion of CAPS-5 total scores (ΔR 2 = 0.024, Δ F(1,125) = 3.539 , p = 0.062). Consistent with our hypothesis, a marginally significant interaction (moderation) effect was found between bilateral hippocampus volume and CSP volume in predicting CAPS-5 total scores at one-month post-trauma (b = -0.0059, t(125) = -1.881, p = 0.062). Examination of this interaction showed a similar pattern to the one mention-above using CAPS-4 total scores: individuals with large CSP had a negative relationship between hippocampal volume and CAPS-5 scores; however, this relationship did not exist in individuals with small or without CSP (see above).
Volumetric predictors of PTSD symptom severity at follow-up assessments (TP2 and TP3)
To further examine the relation between hippocampal and CSP volumes at TP1 and subsequent PTSD symptoms at TP2 and TP3, two additional hierarchical multiple regression analyses were conducted (one for TP2 and one for TP3). The outcome measure for PTSD symptom severity was CAPS-4 total scores (and not CAPS-5), since it presented the more robust findings for TP1.
Focusing on PTSD symptom assessment at six months after trauma (TP2), the hierarchical regression model accounted for a non-significant proportion of the variance in PTSD symptom severity, both without the interaction (R 2 = 0.080, F(6,90) = 1.304 , p = 0.264), and when it was added (ΔR 2 = 0.012, Δ F(1,89) = 1.187 , p = 0.279). Hence, there was no significant moderation (interaction) effect between hippocampal and CSP volumes in predicting CAPS-4 total scores at TP2.
Focusing on PTSD symptom assessment at fourteen months after trauma (TP3), the hierarchical regression model without the interaction accounted for a non-significant proportion of the variance in PTSD symptom severity (R 2 = 0.034, F(6,71) = 0.442 , p = 0.862). After adding the interaction term between hippocampal volume and CSP volume to the regression model, it accounted for a significant proportion of the variance in PTSD symptom severity (ΔR 2 = 0.075, Δ F(1,70) = 5.913 , p = 0.018). A significant interaction (moderation) effect was found between bilateral hippocampus and CSP volumes at TP1 in predicting CAPS-4 total scores at TP3 (b = -0.014, t(70) = -2.432, p = 0.018) (See Table 4 ). Importantly, neither hippocampal volume nor CSP volume by themselves predicted CAPS-4 total scores (p = 0.970; p = 0.996, respectively).
The above-mentioned interaction was probed by testing the conditional effects of CSP volume at the different quartiles of hippocampal volume (Q1=25th percentile, Q2=50th percentile=Median, Q3=75th percentile) (see Fig. 3 ). At low hippocampal volume (Q1), CSP volume was marginally significantly related to PTSD severity (p=0.057). However, at median and high hippocampal volumes (Q2 and Q3 respectively), the relationship between CSP and hippocampus was not significant (p=0.952 and p=0.276 respectively) (see Fig. 3 ).
Discussion
The current study revealed a moderation effect of CSP volume on the relationship between hippocampal volume and PTSD symptom severity in a population of recent trauma survivors.
Specifically, we found that smaller hippocampus volume, together with larger CSP volume, was associated with more severe PTSD symptoms within one-month post-trauma. More so, such relationship at the early aftermath of trauma predicted greater persistence of PTSD at fourteenmonth following trauma exposure. Altogether these findings point to an objective and easy to acquire neuroanatomical signature of PTSD severity among recent trauma survivors, as well as provide a predictive risk factors for persistent chronicity for the disorder. While a great amount of literature suggests the role of hippocampal volume in PTSD 25 , fewer studies have linked abnormal CSP with post-traumatic psychopathology 55, 56 . Our results provide novel insights regarding the relationship between these two brain structures in marking contemporary symptoms and predicting chronic course of PTSD. Importantly, their combined effect supports a brain development origin for PTSD vulnerability following exposure to potentially traumatic event.
Reduced hippocampal volume is the most consistent finding in structural MRI studies of patients diagnosed chronic PTSD [71] [72] [73] [74] . Controversy exists, however, over the nature and source of smaller hippocampal volumes in PTSD; whether volumetric differences represent the consequence of traumatic exposure, or a pre-existing trait that predisposes people to pathological stress reactions to a traumatic event [75] [76] [77] [78] . Our results suggest that in the presence of a smaller hippocampus, an abnormally enlarged CSP might serve as a risk factor for developing PTSD following trauma.
Because an enlarged CSP is considered a neurodevelopmental anomaly, it has been postulated as a potential marker for psychiatric disorders that have neurodevelopmental origins 79 .
As the postnatal closure of the CSP is dependent on adjacent growing brain structures, a risk for developing different psychopathologies might be associated with a combination of both enlarged CSP and smaller limbic system structures (e.g. hippocampus and amygdala) 80 . Here we provide evidence that a combination of enlarged CSP and smaller hippocampal volume might be associated with PTSD symptomatology.
Our study combined early structural brain indices with longitudinal PTSD clinical measures, enabling to examine the relationship between potential neuroanatomical measures and PTSD symptom severity in the first critical year following trauma. Indeed, we demonstrated that enlarged CSP together with smaller hippocampus measured at one-month following exposure, marked PTSD development and predicted their persistence over 14 months. Nevertheless, the combination of enlarged CSP and smaller hippocampus at one-month post-trauma did not significantly predicted symptom severity at six-month post-trauma. This might be explained by the dynamic clinical manifestations during the first critical year following trauma, in which there is a progressive reduction in the severity of PTSD symptoms [81] [82] [83] [84] . An intermediary point of six-month might be too early to capture the tangible chronic PTSD subtype, whereas 14-months may portray a more stable representation of the chronic disorder as it was shown to predict over 90% of expected PTSD recovery 3, 85 .
The methodological strengths of the current study derive from the standardized structural MRI measurements obtained in a large population-based sample of 171 trauma-exposed individuals with different demographic characteristics (e.g. age, gender). In specific, we applied an automated approach for the volume assessment of CSP, yet included only cases that have been also validated by a neurologist (see MRI Analysis). This approach, although commonly applied with the hippocampus, goes beyond the current practice with regard to CSP measurements. Indeed methodological drawbacks, mainly the great variation in the way that the studies detected and quantified CSP, have yet limited a tangible conclusion regarding the contribution of CSP to psychopathology. The most commonly applied method has been a subjective classification by a radiologist of small or large CSP 28,32,36,86 , dependent on different definitions and criteria, resulting in large variability and inconsistencies among raters. Moreover, this manual classification requires both time and expertise. Some researchers adopted more quantitative methods of classification, such as counting the number of slices in which the cavity clearly appears (especially on coronal MRI views), and multiplying it by the slice thickness in order to calculate the anterior-to-posterior length of the cavum 31, 33, 41, 47, 54, 87 . Even with this more quantitate method, there are still conflicting results among the studies that employed such technique 48 . Moreover, such linear measurements only permit a unidimensional representation of the CSP, which can have a complex three-dimensional shape. Volumetric CSP measurement, as employed in this study, may be more meaningful than linear methodologies, since that they provide detailed information about the true size of the structure 88 . Our comprehensive approach of combining automated and manual assessments allowed greater confidence in the results and strengthen findings' generalizability. Having a large sample size allowed to find a sufficient group of individuals with enlarged CSP presence (n=38), thus increasing the statistical power and conclusions.
Although our findings are promising, this work has several limitations. First, as in most PTSD studies, there is a lack of baseline measurement before trauma exposure. However, as structural brain changes typically occur at time frames of months and years, and considering that MRI scans were conducted in here within one-month form exposure, it is plausible to assume that structural abnormalities would reflect pre-disposition factors rather than consequence of trauma exposure. Second, majority of participants suffered from a single trauma, which was mostly related to car accidents. Future work may explore the relationship between these structural brain abnormalities and PTSD symptom severity among varying traumatic events (e.g. terror attacks, sexual or interpersonal violence, continuous traumatic experiences). Lastly, future studies should further examine the relation between hippocampus, CSP and PTSD symptomatology in traumaexposed individuals in order to increase the validity and replicability of out findings.
This study suggests a promising opportunity of an easy-to-detect individual neuroanatomical abnormalities, large CSP and small hippocampus, that together could serve as distinct neuroanatomical signature for the likelihood to develop psychopathology following exposure to traumatic events. Such risk factors can be used meaningfully to improve early diagnostic assessment and since it further predicted long term prognosis of the PTSD, it could also serve as a monitoring marker for treatment outcome. As structural MRI is becoming more available, we could readily identify individuals who could benefit from early intervention following trauma and follow up their clinical course in an objective manner. 
